# Trade Mark Journal No.2026/016 17 April 2026

## WO0000001871887 (42,44,45)

Office of origin: Germany

Date of International Registration:19 March 2025
Date of designation in the UK: 19 March 2025

International priority date claimed: 20 September 2024 (Germany)

Class 42
  Scientific research services in the field of biochemistry [excluding the field of cell culture products], nucleic acids and bioinformatics, in particular molecular biology techniques, especially antisense techniques; design of pharmaceutical active ingredients by means of the aforementioned processes and techniques, including the use of bioinformatics techniques; development of pharmaceutical products by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, including the performance of associated testing and diagnostic procedures; bioinformatic services for the pharmaceutical and biotechnological industry; services for evaluating the efficacy and safety of pharmaceutical products.
Class 44
  Consultancy services to third parties in the field of biochemistry and nucleic acids and bioinformatics, including antisense technology, in relation to the development of pharmaceutical products; consultancy services to third parties in relation to the evaluation of safety and efficacy of pharmaceuticals.
Class 45
  Licensing of industrial property rights arising from the activities of a scientific research organisation in the field of biochemistry [excluding the field of cell culture products], nucleic acids and bioinformatics, in particular molecular biology working techniques, especially antisense technology as well as from the activities of designing active pharmaceutical ingredients by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, from the development of pharmaceutical products by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, including the performance of associated testing and diagnostic procedures, also from the information technology services for the pharmaceutical and biotechnological industry and from the services for evaluating the efficacy and safety of pharmaceutical products.

Secarna Pharmaceuticals GmbH & Co. KG

Representative: Appleyard Lees IP LLP, G Mill, Dean Clough Industrial Park Halifax HX3 5AH UNITED KINGDOM